CNBC
Hantavirus cases spark surge in pharma and biotech stocks — here’s why
EconomyDaily Composite
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
C
Source
CNBC
Read full article at CNBC
Opens original article in a new tab
Advertisement